Neoadjuvant chemotherapy followed by surgery versus upfront surgery in patients with borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.

Authors

null

Junho Kang

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Junho Kang , Changhoon Yoo , Sang Hyun Shin , Kyu-Pyo Kim , Jae Ho Jeong , Heung-Moon Chang , Sang Soo Lee , Do Hyun Park , Tae Jun Song , Dong Wan Seo , Sung Koo Lee , Myung-Hwan Kim , Jin-hong Park , Dae Wook Hwang , Ki Byung Song , Jae Hoon Lee , Baek-Yeol Ryoo , Song Cheol Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 312)

DOI

10.1200/JCO.2019.37.4_suppl.312

Abstract #

312

Poster Bd #

G10

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Non-responders to neoadjuvant chemotherapy in pancreatic adenocarcinoma: Characteristics and outcomes.

Non-responders to neoadjuvant chemotherapy in pancreatic adenocarcinoma: Characteristics and outcomes.

First Author: Brendan Hagerty

First Author: Rixci Ramirez

First Author: Amit Jethanandani